Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Adverse Drug Reaction Reporting by Consumers: India outlook

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: KAUR, Ismeet (Indian Pharmacopoeia Commission, pharmacovigilance, Ghaziabad, India)
  • Co-author(s): Ismeet Kaur: Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ghaziabad, India
    V. Kalaiselvan: Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ghaziabad, India
    Prabhakar Mishra: Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ghaziabad, India
    G.n Singh: Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ghaziabad, India
  • Abstract:

    Backgrounds

    Pharmacovigilance Programme of India (PvPI) is playing a very important role in monitoring Adverse Drug Reactions (ADRs) of the pharmaceutical products moving in the market. The present study aims the reporting culture by the consumers under PvPI.

    Aims

    Consumer reporting has several advantages like good quality reports with full medical

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses